Bio-Rad Laboratories, Inc. Class A Common Stock vs Wheaton Precious Metals Corp — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Wheaton Precious Metals Corp trades at $136.29 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 6.5× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | WPM | |
|---|---|---|
Market Cap | $9.43B | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $356.25 | $165.72 |
52-Week Low | $241.71 | $91.02 |
Enterprise Value | $9.18B | $62.82B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →